Intrinsic Value of S&P & Nasdaq Contact Us

AptarGroup, Inc. ATR NYSE

NYSE • Healthcare • Medical - Instruments & Supplies • US • USD

SharesGrow Score
65/100
4/7 Pass
SharesGrow Intrinsic Value
$204.50
+56.1%
Analyst Price Target
$169.67
+29.5%
SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

AptarGroup, Inc. (ATR) trades at a trailing P/E of 21.7, forward P/E of 23.5. Trailing earnings yield is 4.61%, forward earnings yield 4.26%. PEG 3.34. Graham Number is $75.31.

Criteria proven by this page:

  • VALUE (73/100, Pass) — P/E is below market average (21.7); analyst target implies upside (+29.5%); earnings yield beats bond yields (4.61%).
  • PEG Ratio 3.34 — above 2.0 suggests expensive relative to earnings growth.
  • Trailing Earnings Yield 4.61% — roughly competitive with bond yields (~4.3%), moderate risk-reward.
  • Analyst consensus target $169.67 (+29.5% upside) — significant upside potential according to Wall Street analysts.

Overall SharesGrow Score: 65/100 with 4/7 criteria passed.

SharesGrow 7-Criteria Score
65/100
SG Score
View full scorecard →
VALUE
73/100
Price-to-Earnings & upside
Proven by this page
~
FUTURE
46/100
Analyst consensus
→ Forecast
PAST
100/100
→ Income
HEALTH
83/100
Debt-to-Equity & liquidity
→ Health
MOAT
38/100
→ Income
GROWTH
63/100
→ Income
~
INCOME
55/100
→ Income

Valuation Snapshot — ATR

Valuation Multiples
P/E (TTM)21.7
Forward P/E23.5
PEG Ratio3.34
Forward PEG1.70
P/B Ratio3.19
P/S Ratio2.23
EV/EBITDA11.5
Per Share Data
EPS (TTM)$6.04
Forward EPS (Est.)$5.58
Book Value / Share$41.73
Revenue / Share$58.11
FCF / Share$4.55
Yields & Fair Value
Earnings Yield4.61%
Forward Earnings Yield4.26%
Dividend Yield1.42%
Graham Number$75.31
SharesGrow IV$204.50 (+56.1%)
Analyst Target$169.67 (+29.5%)

Historical Valuation

Year P/E (TTM) PEG Ratio P/B Ratio P/S Ratio Dividend Yield
2016 22.4 8.95 3.93 1.98 1.66%
2017 24.5 3.20 4.11 2.18 1.48%
2018 30.2 -2.65 4.13 2.12 1.40%
2019 30.3 1.37 4.68 2.57 1.23%
2020 41.2 -3.20 4.77 3.01 1.05%
2021 32.9 2.73 4.08 2.49 1.22%
2022 30.1 -18.64 3.50 2.17 1.38%
2023 28.5 1.53 3.52 2.33 1.28%
2024 27.8 0.92 4.22 2.91 1.09%
2025 20.4 3.60 3.01 2.12 1.51%

EPS: Actual vs Estimates

P/E Ratio & Earnings Yield

Earnings Per Share (EPS) History

Year EPS (Diluted) Revenue Net Income Net Margin
2016 $3.17 $2.33B $205.59M 8.8%
2017 $3.41 $2.47B $220.03M 8.9%
2018 $3.00 $2.76B $194.75M 7%
2019 $3.66 $2.86B $242.2M 8.5%
2020 $3.21 $2.93B $214.04M 7.3%
2021 $3.60 $3.23B $244.1M 7.6%
2022 $3.59 $3.32B $239.29M 7.2%
2023 $4.25 $3.49B $284.49M 8.2%
2024 $5.53 $3.58B $374.54M 10.5%
2025 $5.89 $3.78B $392.79M 10.4%

Analyst Estimates

Year EPS (Avg) EPS Range Revenue (Avg) Revenue Range Analysts
2026 $5.59 $5.40 – $5.68 $3.94B $3.91B – $3.98B 6
2027 $6.49 $5.92 – $6.92 $4.13B $4.08B – $4.16B 6
2028 $7.23 $6.90 – $7.55 $4.36B $4.34B – $4.37B 2
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message